TOPLINE: The risk for type 2 diabetes (T2D) was higher in individuals who followed a pro-inflammatory diet and had a high habitual salt intake than in […]

Weight loss drugs have surged in popularity — in part because they work. Patients on glucagon-like peptide 1 (GLP-1) agonists like liraglutide, semaglutide, and tirzepatide (which […]

Stefan Bornstein, MD, PhD, professor, made it clear during a press conference at the 67th Congress of the German Society of Endocrinology (DGE) that there is […]

Tirzepatide (Zepbound for weight loss; Mounjaro for type 2 diabetes; Eli Lilly) consistently reduced body weight regardless of pretreatment body mass index (BMI) and reduced body […]

New data continued to show clinical benefits from continuous glucose monitoring (CGM) in people with type 2 diabetes, including those who don’t use insulin. Use of […]

TOPLINE: Diabetes significantly increases the risks for herpes zoster (HZ) hospitalisation, rehospitalisation, and complications. METHODOLOGY: A two-phase study comparing age-standardised HZ hospitalisation rates between people with […]

Glucagon-like peptide 1 (GLP-1) receptor agonists are the latest blockbuster drugs — thanks to their potent ability to help patients lose weight. But ongoing shortages expected […]

Are you helping your patients with type 1 diabetes make the most of continuous glucose monitoring (CGM) devices? At the Advanced Technologies & Treatments for Diabetes […]

TOPLINE: High-dose ergocalciferol (a vitamin D analog) can prolong the remission period of type 1 diabetes (T1D) by preserving the function of insulin-producing beta cells in […]